Working… Menu

A Randomised Trial of Imatinib Alternating With Regorafenib Compared to Imatinib Alone for the First Line Treatment of Advanced Gastrointestinal Stromal Tumour (GIST) (ALT GIST)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02365441
Recruitment Status : Unknown
Verified September 2016 by Australasian Gastro-Intestinal Trials Group.
Recruitment status was:  Recruiting
First Posted : February 19, 2015
Last Update Posted : October 3, 2016
European Organisation for Research and Treatment of Cancer - EORTC
Scandinavian Sarcoma Group
Information provided by (Responsible Party):
Australasian Gastro-Intestinal Trials Group

No Study Results Posted on for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : December 2019
Estimated Study Completion Date : December 2020